The PSA test has been the gold-standard treatment for detecting prostate cancer, but key shortcomings have prevented national screening programmes.

Recent findings from a study on prostate cancer in Ireland reveal diagnosis disparities, especially in urban areas and middle socioeconomic groups.

Men from the placebo group whose PSA had never exceeded 4.0 ng/ml, who had never previously undergone a prostate biopsy or transurethral prostate resection, and who had consistently normal results ...

New London ― Dean Festa got lucky when he sought to make a change in his life insurance policy. His insurance agent told him ...

Rupert Crowfoot, 57, was diagnosed with prostate cancer last year after a conversation with a friend encouraged him to get a ...

The Duncan Banner will close its office, located at 811 W. Main St., Duncan, to allow employees to spend time with their families. The Banner office will close at noon ...

For Jim O’Donnell, heading into the holiday season this year will be a more uplifting time compared to last year when he was still in treatment for his prostate cancer, working to get back to his ...

CariGenetics has begun enrolment into its multi-country Caribbean prostate cancer study and is calling on Bermudian men to ...

Vice President Kamala Harris addressed her supporters Tuesday (Nov. 26) in a PSA meant to offer encouragement following the ...